Mode
Text Size
Log in / Sign up
Phase 3 N=80 Randomized Double-blind Treatment

Quadratus Lumborum Block Versus Control for Total Hip Arthroplasty

Total Hip Arthroplasty

Enrolled (actual)
80
Serious AEs
0.0%
Results posted
Sep 2020
Primary outcome: Primary: Pain Scores Using Visual Analog Scale (VAS) Scores — 2.34; 3.33 units on a scale

Study Design & Population

Study type
Interventional
Phase
Phase 3
Interventions
Quadratus Lumborum Block (QLB) (Drug); Standard of Care (Drug)
Age
Adult, Older Adult · 18+ yrs
Sex
All
Sponsor
University of Alabama at Birmingham
Primary completion
May 2019

Outcome Measures

OutcomeResultp-value
PRIMARY
Pain Scores Using Visual Analog Scale (VAS) Scores
2.34; 3.33
PRIMARY
Pain Scores Using Visual Analog Scale (VAS) Scores
2.34; 3.33
PRIMARY
Pain Scores Using Visual Analog Scale (VAS) Scores
2.34; 3.33
PRIMARY
Opioid Consumption (Oral Morphine Equivalents)
54.63; 90.76
PRIMARY
Opioid Consumption (Oral Morphine Equivalents)
54.63; 90.76
PRIMARY
Opioid Consumption (Oral Morphine Equivalents)
54.63; 90.76
PRIMARY
Pain Scores Using Visual Analog Scale (VAS) Scores
2.34; 3.33
SECONDARY
Patient Satisfaction
9.14; 7.46
SECONDARY
Hours to Hospital Discharge
53.17; 55.97
SECONDARY
Distance Ambulated
114.51; 100.85
SECONDARY
Distance Ambulated
114.51; 100.85

Summary

Peripheral nerve blocks for joint and extremity surgeries have long been proven to provide effective post-operative analgesia. Of these surgeries, total hip arthroplasty (THA) remains one of the most common orthopedic procedures in the United States with approximately 300,000 operations performed annually. At our institution, post-operative analgesia in these patients is primarily provided through parenteral and oral opioid medications. Quadratus lumborum blocks (QLB) have been described and implemented for various surgical procedures including caesarean and laparoscopic ovarian surgery. Recently, there has been increasing interest in the efficacy of quadratus lumborum blocks for THA. Currently, case reports have established a precedent regarding the efficacy of the QLB for THA in providing superior analgesia and decreasing visual analog pain scores (VAS), but randomized trials are still lacking. The goal of this study is to compare pain scores (VAS), opioid consumption, physical therapy scores, and patient and surgeon satisfaction in patients that receive QLB versus no peripheral nerve blockade in patients undergoing THA. The results of this study have the potential to change standard of care for patients undergoing THA.

Eligibility Criteria

Inclusion Criteria

  • Patients undergoing total hip arthroplasty
  • Adults 18 years of age and older
  • Patients with an American Society of Anesthesiology (ASA) physical status classification of I, II or III

Exclusion Criteria

  • Patients with ASA physical status classification other than I, II, or III
  • Patients with allergies/intolerances to local anesthetic
  • Patients with pre-existing neurologic or anatomic deficits in the lower extremity on the side of the surgical site
  • Patients with coexisting coagulopathy
  • Patients that are pharmacologically anticoagulated will be excluded if placement of peripheral nerve block would be contraindicated according to ASRA (American Society for Regional Anesthesia) guidelines or if spinal anesthesia would be contraindicated according to guidelines
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03408483). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search